| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 219.25B | 218.33B | 214.89B | 195.88B | 174.62B | 139.43B |
| Gross Profit | 32.38B | 32.19B | 31.85B | 32.34B | 35.70B | 26.24B |
| EBITDA | 28.81B | 26.03B | 30.54B | 29.69B | 32.12B | 23.56B |
| Net Income | 9.33B | 3.15B | 12.22B | 15.54B | 17.58B | 11.78B |
Balance Sheet | ||||||
| Total Assets | 234.39B | 240.99B | 223.70B | 195.70B | 159.80B | 134.04B |
| Cash, Cash Equivalents and Short-Term Investments | 56.43B | 53.04B | 49.88B | 39.25B | 33.94B | 31.31B |
| Total Debt | 86.85B | 87.27B | 76.37B | 62.48B | 51.05B | 48.88B |
| Total Liabilities | 125.06B | 127.38B | 113.37B | 98.70B | 79.19B | 72.65B |
| Stockholders Equity | 108.99B | 113.25B | 109.98B | 96.63B | 80.31B | 61.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.49B | -1.46B | -4.04B | 651.00M | 369.00M |
| Operating Cash Flow | 0.00 | 24.14B | 24.37B | 31.68B | 22.08B | 18.13B |
| Investing Cash Flow | 0.00 | -28.77B | -26.51B | -36.39B | -19.59B | -17.74B |
| Financing Cash Flow | 0.00 | 7.12B | 11.07B | 8.83B | -665.00M | 12.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥87.24B | 15.26 | 12.96% | 1.36% | 19.33% | 20.49% | |
77 Outperform | ¥715.68B | 24.84 | 12.66% | 2.28% | 7.69% | -19.63% | |
76 Outperform | ¥351.74B | 15.35 | 5.77% | 3.28% | 10.58% | -7.25% | |
71 Outperform | ¥481.67B | 22.63 | ― | 1.02% | 26.11% | 36.35% | |
66 Neutral | ¥640.48B | 30.45 | ― | 0.79% | 3.53% | -18.43% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | ¥121.53B | 43.14 | ― | 2.45% | 1.60% | -74.21% |